UI Health | Strategic Alliance Partners

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

Stephanie Y. Crawford, PhD, MPH, highlights the expanded roles of pharmacists in clinical and non-clinical settings and their increased role in patient care, sharing personal experiences where pharmacists have been instrumental in supporting her family's health needs.

Each therapy presents a different but effective treatment option.

Moderator Curtis E. Haas, PharmD, FCCP; Deborah Simonson, PharmD; Andrew J. Donnelly, PharmD, MBA, FASHP; Noelle Chapman, PharmD, MBA, BCPS, FASHP; Todd Nesbit, PharmD, MBA, FASHP, discuss current challenges facing health-system pharmacies as well as potential solutions in areas such as staffing and financial stress.

Burnout, drug and technician shortages, home care, remote work, and telehealth continue to trend

Tina Saleh, PharmD, PGY1 specialty pharmacy resident at the University of Illinois Hospital and Health Science System, discusses how oral anticancer agents differ from infusions and how pharmacists can improve tolerability for patients.

Institutions are replacing innovator biologics with their biosimilars, often to take advantage of the financial benefits.

Drug shortages and rising prices remain a major issue, with drug pricing legislation on a national level going nowhere fast, and a new gene therapy becoming the most expensive drug approved by the FDA. The opioid epidemic continues to hold the attention of health care providers and organizations, and burnout is increasingly recognized as a problem that needs addressing.

As Andrew J. Donnelly, PharmD, MBA, FASHP, the director of pharmacy at the University of Illinois Hospital and Health Sciences System in Chicago and a clinical professor and the associate dean for clinical affairs at the University of Illinois at Chicago College of Pharmacy, reports in our cover feature, this year’s hot topics included medication shortages, rising drug prices, legislation, a new gene therapy, the opioid epidemic, and the proliferation of cannabidiol products.

The United States is on the cusp of seeing significantly more activity related to these products.